Clin2
NCT06928246Possibly a fitRecruiting

Botox for Eczema: A Skin & Nerve Study

Atopic Dermatitis (AD)

Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.

This trial tests whether Botox injections can improve eczema by calming nerve-immune system interactions. It is for adults with mild-to-moderate eczema who have not used certain stronger treatments recently.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
8 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years or older.
  • Your eczema should be mild to moderate (not severe).
  • You cannot have used any strong eczema creams or pills in the past 4 weeks (or 3 months for certain medications).
  • You must not have had prior biologic treatments (like Dupixent) or certain systemic drugs (like methotrexate).
  • You cannot be pregnant or breastfeeding.
  • You must not have serious health conditions that make skin biopsies risky.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07175233Not yet recruiting· Phase 2
Study of SIM0278 for moderate to severe eczema

This trial tests an experimental drug called SIM0278 for people with moderate to severe atopic dermatitis (eczema). It aims to see if the drug can reduce skin symptoms and is safe to use.

Hangzhou
NCT07488065Recruiting· Phase 1
New drug for moderate to severe eczema

This trial tests a new injectable drug called SKB575 for people with moderate to severe atopic dermatitis (eczema). It aims to see how safe and effective the drug is, especially for those who haven't had success with strong creams or pills.

Shanghai
NCT06055361Recruiting· Phase 1
Studying a new injection for moderate to severe eczema

This trial tests an investigational drug called BxC-I17e, given as an injection under the skin, for people with moderate to severe atopic dermatitis (eczema) that hasn't improved enough with standard creams. The goal is to see if it is safe and works well.

North Little Rock, Arkansas
NCT07377838Not yet recruiting· Phase 3
Stem cell injection for moderate to severe eczema

This trial tests a new stem cell injection called ADSTEM for people with moderate to severe eczema that hasn't improved with standard treatments. The goal is to see if it can reduce eczema symptoms like itching, redness, and skin rash.

NCT06808477Recruiting· Phase 1
BBT001 for moderate to severe eczema

This trial tests an experimental drug called BBT001 for people with moderate to severe eczema (atopic dermatitis) that hasn't been helped enough by creams. The study is in early phases, so it will check how safe the drug is and how well it might work.

Irvine, California
NCT06922565Not yet recruiting
Acupuncture for moderate to severe eczema

This trial tests whether acupuncture can help people with moderate-to-severe atopic dermatitis (eczema) feel less itchy. If you have persistent itch and are between 18 and 75 years old, you may qualify.

Hear when a new Atopic Dermatitis (AD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.